Trial Profile
Phase I study of BCNU [carmustine] plus 06-benzylguanine in patients with recurrent, persistent, or progressive cerebral anaplastic gliomas.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Benzylguanine (Primary) ; Carmustine (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma
- Focus Adverse reactions
- 13 Dec 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 20 Sep 2005 New trial record.